Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

Boehm, Thomas, Folkman, Judah, Browder, Timothy, O'Reilly, Michael S.·1997·Nature
DOI 10.1038/37126

Cited by (1,002)

Items 301–400 of 1,002

  1. Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention
    Tariq A. Bhat, Dhanya K. Nambiar, Ajantaa Pal, Rajesh Agarwal, Rana Pratap Singh · 2011 · Carcinogenesis
  2. SYNTHESIS: Cancer research meets evolutionary biology
    John W. Pepper, C. Scott Findlay, Rees Kassen, Sabrina L. Spencer, Carlo C. Maley · 2009 · Evolutionary Applications
  3. Opposing effects of hypoxia on expression of the angiogenic inhibitor thrombospondin 1 and the angiogenic inducer vascular endothelial growth factor.
    Keith R. Laderoute, Rodolfo M. Alarcon, M D Brody, Joy M. Calaoagan, Eunice Y. Chen, A. Merrill Knapp, Zhong Yun, Nicholas C. Denko, Amato J. Giaccia · 2000 · PubMed
  4. Modeling and predicting clinical efficacy for drugs targeting the tumor milieu
    Mallika Singh, Napoleone Ferrara · 2012 · Nature Biotechnology
  5. Localization of Collagen XVIII and the Endostatin Portion of Collagen XVIII in Aged Human Control Eyes and Eyes with Age-Related Macular Degeneration
    Imran Ahmed Bhutto · 2004 · Investigative Ophthalmology & Visual Science
  6. Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library.
    Z Zhu, Patricia Rockwell, Dan Lu, Helen Kotanides, Bronislaw Pytowski, Daniel J. Hicklin, Peter Böhlen, L Witte · 1998 · PubMed
  7. Contortrostatin, a dimeric disintegrin from contortrix contortrix, inhibits breast cancer progression
    Qing Zhou, Russel P. Sherwin, Catherine Parrish, Valda Richters, Susan G. Groshen, Denice D Tsao-Wei, Francis S. Markland · 2000 · Breast Cancer Research and Treatment
  8. Angiogenesis inhibitors target the endothelial cell cytoskeleton through altered regulation of heat shock protein 27 and cofilin.
    Susan M. Keezer, Susan E. Ivie, Henry C. Krutzsch, Anita T. Tandle, Steven K. Libutti, David D. Roberts · 2003 · PubMed
  9. Thalidomide: Tragic Past and Promising Future
    S. Vincent Rajkumar · 2004 · Mayo Clinic Proceedings
  10. Targeting angiogenesis: a review of angiogenesis inhibitors in the treatment of lung cancer
    Srikala S. Sridhar, Frances A. Shepherd · 2003 · Lung Cancer
  11. Tumor angiogenesis: Molecular pathology, therapeutic targeting, and imaging
    William W. Li · 2000 · Academic Radiology
  12. Antifungal Activities of Antineoplastic Agents: Saccharomyces cerevisiae as a Model System To Study Drug Action
    Maria Elena Cardenas, Maria Cristina Cruz, Maurizio Del Poeta, Namjin Chung, John R. Perfect, Joseph Heitman · 1999 · Clinical Microbiology Reviews
  13. ANGIOGENESIS and ANGIOGENIC MEDIATORS IN HAEMATOLOGICAL MALIGNANCIES
    Manzoor H. Mangi, Adrian C. Newland · 2000 · British Journal of Haematology
  14. In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects
    Stéphanie Filleur, Olga V. Volpert, Armelle Degeorges, Carole Voland, F. Reiher, Philippe Clézardin, Noël Bouck, Florence Cabon · 2001 · Genes & Development
  15. A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma
    Chuanliang Cui, Lili Mao, Zhihong Chi, Lu Si, Xinan Sheng, Yan Kong, Siming Li, Bin Lian, Kangsheng Gu, Min Tao et al. · 2013 · Molecular Therapy
  16. Antiangiogenic Therapies: Going beyond Their Limits
    Lidia Moserle, Gabriela Jiménez-Valerio, Oriol Casanovas · 2013 · Cancer Discovery
  17. Sulfonamide derivative, E7820, is a unique angiogenesis inhibitor suppressing an expression of integrin alpha2 subunit on endothelium.
    Yasuhiro Funahashi, Naoko Hata Sugi, Taro Semba, Yuji Yamamoto, Shinichi Hamaoka, Naoko Tsukahara-Tamai, Yoichi Ozawa, Akihiko Tsuruoka, Kazumasa Nara, Keiko Takahashi et al. · 2002 · PubMed
  18. What do oncogenic mutations have to do with angiogenesis/vascular dependence of tumors?
    Janusz W. Rak, Joanne Yu, Robert S. Kerbel, Brenda Lynn Coomber · 2002 · PubMed
  19. Collagen biology making inroads into prognosis and treatment of cancer progression and metastasis
    Ana C. Martins Cavaco, Sara Dâmaso, Sandra Casimiro, Luís Costa · 2020 · Cancer and Metastasis Reviews
  20. Mcl-1 Antisense Therapy Chemosensitizes Human Melanoma in a SCID Mouse Xenotransplantation Model
    Christiane Thallinger, Markus F. Wolschek, Volker Wacheck, Helmut Maierhofer, Patrick Günsberg, Peter Polterauer, Hubert Pehamberger, Brett P. Monia, Edgar Selzer, Klaus S. Wolff et al. · 2003 · Journal of Investigative Dermatology
  21. Vascular Remodeling Marks Tumors That Recur During Chronic Suppression of Angiogenesis
    Jianzhong Huang, Samuel Z. Soffer, Eugene S. Kim, Kimberly W. McCrudden, Joe T. Huang, Tamara N. New, Christina A. Manley, William Middlesworth, Kathleen O’Toole, Darrell J. Yamashiro et al. · 2004 · Molecular Cancer Research
  22. Factors Promoting Tumor Angiogenesis
    Marie E. Beckner · 1999 · Cancer Investigation
  23. New Technologies and Directed Agents for Applications of Cancer Imaging
    Mostafa Atri · 2006 · Journal of Clinical Oncology
  24. Angiogenesis and non-small cell lung cancer
    Giles Cox · 2000 · Lung Cancer
  25. A top-down view of the tumor microenvironment: structure, cells and signaling
    Rahul Bhome, Marc D. Bullock, Hajir AlSaihati, Rebecca W. Goh, John M. Primrose, Emre Sayan, Alex H. Mirnezami · 2015 · Frontiers in Cell and Developmental Biology
  26. Simultaneous measurement of arterial input function and tumor pharmacokinetics in mice by dynamic contrast enhanced imaging: Effects of transcytolemmal water exchange
    Rong Zhou, Stephen Pickup, Thomas E. Yankeelov, CHARLES S. JUN. SPRINGER, Jerry D. Glickson · 2004 · Magnetic Resonance in Medicine
  27. Inhibition of Angiogenesis by Humulone, a Bitter Acid from Beer Hop
    Mariko Shimamura, Tadahiko Hazato, Hiromi Ashino, Yukio Yamamoto, Eri Iwasaki, Hiroyasu Tobe, Kei Yamamoto, Shozo Yamamoto · 2001 · Biochemical and Biophysical Research Communications
  28. Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line
    Tamara Minko, Pavla Kopečková, Jindŕich Kopec̆ek · 1999 · Journal of Controlled Release
  29. A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis
    Susanna Lewén, He Zhou, Huaidong Hu, Tingmei Cheng, Dorothy Markowitz, Ralph A. Reisfeld, Rong Xiang, Yunping Luo · 2007 · Cancer Immunology Immunotherapy
  30. The angiogenesis inhibitor tnp-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease.
    Suzanne Shusterman, Stephan A. Grupp, Ronald Duncan Barr, David F. Carpentieri, Huaqing Zhao, John M. Maris · 2001 · PubMed
  31. Anti-Angiogenic Activity of Selected Receptor Tyrosine Kinase Inhibitors, PD166285 and PD173074: Implications for Combination Treatment with Photodynamic Therapy
    Charles J. Dimitroff, Wayne D. Klohs, Amarnath Sharma, Paula J. Pera, Denise L. Driscoll, Jean M. Veith, Randall W. Steinkampf, Mel C. Schroeder, Sylvester R. Klutchko, Adam B. Sumlin et al. · 1999 · Investigational New Drugs
  32. Molecular regulation of tumor angiogenesis: mechanisms and therapeutic implications
    Jay W. Harper, Marsha A. Moses · 2006 · Birkhäuser Basel eBooks
  33. Anti-angiogenic agents
    G. Deplanque, Adrian Llewellyn Harris · 2000 · European Journal of Cancer
  34. Endostatin gene therapy delivered by <i>Salmonella choleraesuis</i> in murine tumor models
    Lee, Che‐Hsin, Wu, Chao‐Liang, Shiau, Ai‐Li · 2004 · The Journal of Gene Medicine
  35. The copper chelator trientine has an antiangiogenic effect against hepatocellular carcinoma, possibly through inhibition of interleukin‐8 production
    Michihisa Moriguchi, Tomoki Nakajima, Hiroyuki Kimura, Tadashi Watanabe, Hidetaka Takashima, Yasuhide Mitsumoto, Tatsuo Katagishi, Takeshi Okanoue, Keizo Kagawa · 2002 · International Journal of Cancer
  36. Combining Agents that Target the Tumor Microenvironment Improves the Efficacy of Anticancer Therapy
    Joseph Blansfield, Diana L. Caragacianu, Henry Richard Alexander, Michael A. Tangrea, Shane Young Morita, Dominique Lorang, Peter H Schafer, George W. Muller, David Stirling, Richard Eldon Royal et al. · 2008 · Clinical Cancer Research
  37. Endogenous inhibitors of angiogenesis in malignant gliomas: Nature's antiangiogenic therapy
    Tanya A. Rege, Constance Y. Fears, Candece L. Gladson · 2005 · Neuro-Oncology
  38. Inhibition of Tumor Growth and Metastasis by Targeting Tumor-Associated Angiogenesis with Antagonists to the Receptors of Vascular Endothelial Growth Factor
    Zhenping Zhu, Larry Witte · 1999 · Investigational New Drugs
  39. Angiostatin and Endostatin: Endogenous Inhibitors of Tumor Growth
    B. Kim Lee Sim, Nicholas J. MacDonald, E R Gubish · 2000 · Cancer and Metastasis Reviews
  40. Antitumor activity of endostatin against carcinogen-induced rat primary mammary tumors.
    Gianpaolo Perletti, Paola Concari, Roberto Giardini, Emanuela Marras, F Piccinini, Judah Folkman, Lina Chen · 2000 · PubMed
  41. Exosomal Non-Coding RNAs: Diagnostic, Prognostic and Therapeutic Applications in Cancer
    Marc D. Bullock, Andreia Machado da Silva, Pınar Kanlikilicer, Justyna Filant, Mohammed Helmy Rashed, Anil K. Sood, Gabriel Lopez‐Berestein, George A. Călin · 2015 · Non-Coding RNA
  42. Effects of Naturally Occurring Stilbene Glucosides from Medicinal Plants and Wine, on Tumour Growth and Lung Metastasis in Lewis Lung Carcinoma-Bearing Mice
    Yoshiyuki Kimura, Hiromichi Okuda · 2000 · Journal of Pharmacy and Pharmacology
  43. Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis
    Urszula Ledzewicz, Heinz Schättler · 2008 · Journal of Theoretical Biology
  44. Tumour‐associated angiogenesis in human colorectal cancer
    Khaled A Rmali, M. C. A. Puntis, Wen G. Jiang · 2006 · Colorectal Disease
  45. Cancer Therapeutics- Opportunities, Challenges and Advances in Drug Delivery
    Deepak D Kakde, Rajendra Baliram Kakde, agadevappa Patil, Deepti Jain, Vivek Shrivastava · 2011
  46. Cyclin‐dependent kinase 4 is a novel target in micoRNA‐195‐mediated cell cycle arrest in bladder cancer cells
    Yiwei Lin, Jian Wu, Hong Chen, Yeqing Mao, Yunfu Liu, Qiqi Mao, Kai Ge Yang, Xiangyi Zheng, Liping Xie · 2012 · FEBS Letters
  47. Cellular interactions in vascular growth and differentiation
    Louis L. Nguyen, Patrìcia A. D'Amore · 2001 · International review of cytology
  48. Endostatin Inhibits Microvessel Formation in the ex Vivo Rat Aortic Ring Angiogenesis Assay
    Erwin A. Kruger, Paul H. Duray, Maria Tsokos, David J. Venzon, Steven K. Libutti, Shannon C. Dixon, Michelle A. Rudek, James M. Pluda, Carmen Joseph Allegra, William Douglas Figg · 2000 · Biochemical and Biophysical Research Communications
  49. Combretastatin A4 Phosphate: A Novel Vascular Disrupting Agent
    Govardhanan Nagaiah, Scot C. Remick · 2010 · Future Oncology
  50. Current Status Of Antiangiogenic Factors
    Kate Talks, Adrian Llewellyn Harris · 2000 · British Journal of Haematology
  51. Activation of Akt-mTOR-p70S6K pathway in angiogenesis in hepatocellular carcinoma
    Wěi Li · 1994 · Oncology Reports
  52. Hemostatic Regulators of Tumor Angiogenesis: A Source of Antiangiogenic Agents for Cancer Treatment?
    Martina E. Daly · 2003 · JNCI Journal of the National Cancer Institute
  53. Incipient Angiogenesis
    Judah Folkman · 2000 · JNCI Journal of the National Cancer Institute
  54. CD36 A critical anti angiogenic receptor
    Ronit Simantov · 2003 · Frontiers in bioscience
  55. Circulating Endothelial Cells as a Novel Marker of Angiogenesis
    Patrizia Mancuso, Angelica Calleri, Cristina Cassi, Alberto Gobbi, Manuela Capillo, Giancarlo Pruneri, Giovanni Martinelli, Francesco Bertolini · 2003 · Advances in experimental medicine and biology
  56. Modulation of the tumor vasculature functionality by ionizing radiation accounts for tumor radiosensitization and promotes gene delivery
    Pierre Sonveaux, Chantal Dessy, Agnès Brouet, Bénédicte F. Jordan, Vincent Grégoire, Bernard Gallez, Jean‐Luc Balligand, Olivier Féron · 2002 · The FASEB Journal
  57. Metronomic administration of chlorambucil for treatment of dogs with urinary bladder transitional cell carcinoma
    Diane Schrempp, Michael O. Childress, Jane C. Stewart, T. N. Leach, Kean Ming Tan, Andrew H. Abbo, Amalia E. de Gortari, Patty L. Bonney, Deborah W. Knapp · 2013 · Journal of the American Veterinary Medical Association
  58. Octacosanol isolated from Tinospora cordifolia downregulates VEGF gene expression by inhibiting nuclear translocation of NF-<kappa>B and its DNA binding activity
    G. B. Thippeswamy, M.L. Sheela, Bharathi P. Salimath · 2008 · European Journal of Pharmacology
  59. MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway
    Erica Lorenzon, Roberta Colladel, Eva Andreuzzi, Stefano Marastoni, Federico Todaro, Mónica Schiappacassi, Giovanni Ligresti, Alfonso Colombatti, Maurizio Mongiat · 2011 · Oncogene
  60. Gene Transfer of IFN-γ into Established Brain Tumors Represses Growth by Antiangiogenesis
    Hassan M. Fathallah‐Shaykh, Li-Juan Zhao, Abdallah I. Kafrouni, George M. Smith, James Forman · 2000 · The Journal of Immunology
  61. Mouse macrophage metalloelastase gene transfer into a murine melanoma suppresses primary tumor growth by halting angiogenesis.
    Manuel J. Gorrín-Rivas, Shigeki Arii, M Furutani, Masaki Mizumoto, Akira Mori, Koji Hanaki, Makiko Maeda, H Furuyama, Yoko Kondo, M Imamura · 2000 · PubMed
  62. Inhibition of Angiogenesis: Treatment Options for Patients with Metastatic Prostate Cancer
    William Douglas Figg, Erwin A. Kruger, Douglas K. Price, Sonia Kim, William Dahut · 2002 · Investigational New Drugs
  63. Antiangiogenic Gene Therapy for Cancer via Systemic Administration of Adenoviral Vectors Expressing Secretable Endostatin
    Cheauyun T. Chen, Jane Lin, Qin Li, Sandrina S. Phipps, John L. Jakubczak, David Alan Stewart, Yelena Skripchenko, Suzanne Forry‐Schaudies, Jeanette Marjorie Wood, Christian Schnell et al. · 2000 · Human Gene Therapy
  64. Vascular remodeling and clinical resistance to antiangiogenic cancer therapy
    J GLADEBENDER, E COONEY, J KANDEL, Darrell J. Yamashiro · 2004 · Drug Resistance Updates
  65. Tissue examination to monitor antiangiogenic therapy: a phase I clinical trial with endostatin.
    Christoph Mundhenke, James P. Thomas, George Wilding, Fred T. Lee, Fred Kelzc, Rick J Chappell, Rosemary S. Neider, Linda Sebree, Andreas Friedl · 2001 · PubMed
  66. Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin lymphoma
    Francesco Bertolini, Lisa Fusetti, Patrizia Mancuso, Alberto Gobbi, Chiara Antonia Corsini, Pier Francesco Ferrucci, Giovanni Martinelli, Giancarlo Pruneri · 2000 · Blood
  67. Gene therapy for cancer
    Jesús Gómez-Navarro, Curiel Dt, Joanne T. Douglas · 1999 · European Journal of Cancer
  68. Breast cancer during pregnancy.
    L M Ellis, W Liu, F Fan, N Reinmuth, R M Shaheen, Y D Jung, S Ahmad · 2001 · PubMed
  69. Expression of Peroxisome Proliferator-Activated Receptor γ in Renal Cell Carcinoma and Growth Inhibition by Its Agonists
    Kenichi Inoue, Yutaka Kawahito, Yasunori Tsubouchi, Masataka Kohno, Rikio Yoshimura, Toshikazu Yoshikawa, Hajime Sano · 2001 · Biochemical and Biophysical Research Communications
  70. Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells
    Wei Zhuo, Chong T. Luo, Xiaofeng Wang, Xiaomin Song, Yan Fu, Yongzhang Luo · 2010 · The Journal of Pathology
  71. Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies.
    David R. Shalinsky, John Brekken, Helen Y. Zou, L A Bloom, Colleen D. McDermott, S. Zook, Nissi M. Varki, Krzysztof Appelt · 1999 · PubMed
  72. Transformation of the microvascular system during multistage tumorigenesis
    Eduard Ryschich, Jan Schmidt, Günter Joachim Hämmerling, Ernst Klar, Ruth Ganß · 2002 · International Journal of Cancer
  73. Vascularization is a general requirement for growth of plant and animal tumours
    C. Ullrich, Roni Aloni · 2000 · Journal of Experimental Botany
  74. Antivascular Treatment of Solid Melanoma Tumors with Bacteriochlorophyll-serine-based Photodynamic Therapy¶
    Judith Zilberstein, Smadar Schreiber, Monique C. W. M. Bloemers, Peter Bendel, Michal Neeman, Edna Schechtman, Förtüne Kohen, Avigdor Joshua Scherz, Yoram Salomon · 2001 · Photochemistry and Photobiology
  75. 2-Methoxyestradiol – a unique blend of activities generating a new class of anti-tumour/anti-inflammatory agents
    Tara E. Sutherland, Robin L. Anderson, Richard A. Hughes, Emile Altmann, Michael J. Schuliga, James Ziogas, Alastair G. Stewart · 2007 · Drug Discovery Today
  76. Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma
    Monica Loi, Serena Marchiò, Pamela Becherini, Daniela Di Paolo, Marco Soster, Flavio Curnis, Chiara Brignole, Gabriella Pagnan, Patrizia Perri, Irene Caffa · 2010 · Journal of Controlled Release
  77. Review: Frontiers of Antifibrotic Therapy in Systemic Sclerosis
    Jörg H. W. Distler, Carol A. Feghali‐Bostwick, Alina Soare, Yoshihide Asano, Oliver Distler, David Abraham · 2016 · Arthritis & Rheumatology
  78. Disassembly of Hydrophobic Photosensitizer by Biodegradable Zeolitic Imidazolate Framework-8 for Photodynamic Cancer Therapy
    Dandan Xu, Yongqiang You, Fanyu Zeng, Yong Wang, Chunyan Liang, Huanhuan Feng, Xing Ma · 2018 · ACS Applied Materials & Interfaces
  79. Cutting Edge: Systemic Inhibition of Angiogenesis Underlies Resistance to Tumors During Acute Toxoplasmosis
    Christopher A. Hunter, Duonan Yu, Michael Stanley Gee, Cam V. Ngo, Cinzia Sevignani, Michael H. Goldschmidt, Tatyana V. Golovkina, Sydney M. Evans, William F. Lee, Andrei Thomas‐Tikhonenko · 2001 · The Journal of Immunology
  80. Mechanisms for 2‐methoxyestradiol‐induced apoptosis of prostate cancer cells
    Shizhong Bu, Andree Blaukat, Xin Fu, Nils‐Erik Heldin, Maréne Landström · 2002 · FEBS Letters
  81. Intratumoral cytogenetic heterogeneity detected by comparative genomic hybridization and laser scanning cytometry in human gliomas.
    Katsumi Harada, Takafumi Nishizaki, S Ozaki, Hisashi Kubota, Haruhide Ito, Kohsuke Sasaki · 1998 · PubMed
  82. Anti-vascular tumor therapy: recent advances, pitfalls and clinical perspectives
    Martin Eichhorn, Sebastian Strieth, Marc Dellian · 2004 · Drug Resistance Updates
  83. Reversal of intrinsic and acquired forms of drug resistance by hyaluronidase treatment of solid tumors
    Brad St. Croix, Shan Man, Robert S. Kerbel · 1998 · Cancer Letters
  84. Advances in pretargeting biotechnology
    David A. Goodwin, Claude F. Meares · 2001 · Biotechnology Advances
  85. Antitumor effects of Stat3-siRNA and endostatin combined therapies, delivered by attenuated Salmonella, on orthotopically implanted hepatocarcinoma
    Huijie Jia, Yang Li, Tiesuo Zhao, Xin Li, Jiadi Hu, Di Yin, Baofeng Guo, Dennis J. Kopecko, Xuejian Zhao, Ling Zhang et al. · 2012 · Cancer Immunology Immunotherapy
  86. Review: Monoclonal Antibodies to the Vascular Endothelial Growth Factor Receptor-2 in Cancer Therapy
    Hagop Youssoufian, Daniel J. Hicklin, Eric Keith Rowinsky · 2007 · Clinical Cancer Research
  87. Antiangiogenic and antimetastatic properties of Neovastat (Æ-941), an orally active extract derived from cartilage tissue
    Éric Dupont, Pierre Falardeau, Shaker A. Mousa, Violetta Dimitriadou, Marie-Claude Pépin, Taiqi Wang, Moulay A. Alaoui‐Jamali · 2002 · Clinical & Experimental Metastasis
  88. A phase I and pharmacokinetic study of squalamine, a novel antiangiogenic agent, in patients with advanced cancers.
    Pankaj Bhargava, J L Marshall, William Dahut, N. Rizvi, Nina M. Trocky, Jon I. Williams, Howard I. Hait, Sang Hoon Song, Kenneth J. Holroyd, Michael Hawkins · 2001 · PubMed
  89. Inhibitory Effect of Full-Length Human Endostatin on in Vitro Angiogenesis
    Letizia Taddei, Paola Chiarugi, Laura Brogelli, Paolo Cirri, Lucia Magnelli, Giovanni Raugei, Marina Ziche, Harris J. Granger, Vincenzo P. Chiarugi, Giampietro Ramponi · 1999 · Biochemical and Biophysical Research Communications
  90. Interglandular cytogenetic heterogeneity detected by comparative genomic hybridization in pancreatic cancer.
    Tomohiko Harada, Kiwamu Okita, Kei Shiraishi, Noriyoshi Kusano, Satoshi Kondoh, Kohsuke Sasaki · 2002 · PubMed
  91. Differential effects of angiostatin, endostatin and interferon-α1 gene transfer on in vivo growth of human breast cancer cells
    Stefano Indraccolo, E Gola, Antonio Rosato, Sonia Anna Minuzzo, Walter Habeler, Veronica Tisato, Valeria Roni, Giovanni Esposito, Monica Morini, Adriana Albini et al. · 2002 · Gene Therapy
  92. NC1 Domain of Human Type VIII Collagen (α 1) Inhibits Bovine Aortic Endothelial Cell Proliferation and Causes Cell Apoptosis
    Ren Xu, Zhong-Yin Yao, Li Xin, Qian Zhang, Tsaiping Li, Ren-Bao Gan · 2001 · Biochemical and Biophysical Research Communications
  93. Macrophage colony stimulating factor: Not just for macrophages anymore! A gateway into complex biologies
    Thomas G. Douglass, Lara Driggers, Jian Gang Zhang, Neil T. Hoa, Christina Delgado, Christopher Charles Williams, Qinhong Dan, Ramon Sanchez, Edward W. B. Jeffes, H. Terry Wepsic et al. · 2008 · International Immunopharmacology
  94. Anti‐neovascular therapy by liposomal drug targeted to membrane type‐1 matrix metalloproteinase
    Masami Kondo, Tomohiro Asai, Yasufumi Katanasaka, Yasuyuki Sadzuka, Hideo Tsukada, Koichi Ogino, Takao Taki, Kazuhiko Baba, Naoto Oku · 2003 · International Journal of Cancer
  95. Probing the Interactions of Phosphosulfomannans with Angiogenic Growth Factors by Surface Plasmon Resonance
    Siska Cochran, Caiping Li, Jon K. Fairweather, Warren C. Kett, Deirdre R. Coombe, Vito Ferro · 2003 · Journal of Medicinal Chemistry
  96. Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats
    Da-Xin Zhang, P.L. Paul Kaufman, Guoquan Gao, Richard A. Saunders, J. X. · 2001 · Diabetologia
  97. Endostatin dramatically inhibits endothelial cell migration, vascular morphogenesis, and perivascular cell recruitment in vivo
    Dag K. Skovseth, Marjan J. T. Veuger, Dag Reidar Sørensen, Paula M. De Angelis, Guttorm Haraldsen · 2004 · Blood
  98. The thin red line
    Francesco Bertolini, Patrizia Mancuso, Alberto Gobbi, Giancarlo Pruneri · 2000 · Experimental Hematology
  99. Angiostatin-mediated Suppression of Cancer Metastases by Primary Neoplasms Engineered to Produce Granulocyte/Macrophage Colony–stimulating Factor
    Zhongyun Dong, Junya Yoneda, Rakesh Kumar, Isaiah J. Fidler · 1998 · The Journal of Experimental Medicine
  100. Antiangiogenesis beyond VEGF inhibition: A journey from antiangiogenic single-target to broad-spectrum agents
    Gabriel Limaverde‐Sousa, Cinthya Sternberg, Carlos Gil Ferreira · 2013 · Cancer Treatment Reviews